Trop2 is expressed at low levels on the surface of normal epithelial cells and at high levels in many epithelial tumors, such as colon, pancreatic and breast cancer, making it an ideal target for cancer therapy [9]. This evidence concerns the gene TACSTD2 and breast carcinoma.